Notable from Our Podcast
The April 30, 2019, podcast interview highlighted a mouse model of anti-NMDA receptor post–herpes simplex encephalitis. What's Trending discusses ataxias.
Author Tip
Neurology strives to publish superb studies in clinical neurology. Peer reviewers' opinions of manuscripts are invaluable in assisting the Editor-in-Chief and Associate Editors' decisions. In addition to helping assess manuscripts, reviewers recommend areas for the author to address and improve in their manuscripts. Reviewing for Neurology presents opportunities to stay abreast of current research and gain understandings that will improve the quality of your own studies and how you report them. If you are interested in reviewing, contact us at journal{at}neurology.org and include a series of keywords on topics in which you have expertise.
From the AAN Press Room
Visit AAN.com/pressroom for the latest press releases
Study: An Aspirin a Day Does Not Keep Dementia at Bay
Taking a low-dose aspirin once a day does not reduce the risk of thinking and memory problems caused by mild cognitive impairment or probable Alzheimer disease, nor does it slow the rate of cognitive decline. “Worldwide, an estimated 50 million people have some form of dementia, a number that is expected to grow as the population increases, so the scientific community is eager to find a low-cost treatment that may reduce a person's risk,” said study author Joanne Ryan, PhD.
Ryan J, Storey E, Murray AM et al. Neurology 2020; doi.org/10.1212/WNL.0000000000009277
CME
Effect of yoga as add-on therapy in migraine (CONTAIN): A randomized clinical trial
Page 912
Aerobic exercise improves cognition and cerebrovascular regulation in older adults
Page 916
Most-Read Articles
As of October 2 2019
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
G. McKhann, D. Drachman, M. Folstein, et al. 1984;34:939–944. doi.org/10.1212/WNL.34.7.939
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
J.F. Kurtzke. 1983;33:1444–1452. doi.org/10.1212/WNL.33.11.1444
Parkinsonism: onset, progression, and mortality
M.M. Hoehn and M.D. Yahr. 1967;17:427–442. doi.org/10.1212/WNL.17.5.427
Neurosurgical horizons in Parkinson's disease
C.G. Goetz, M.R. De Long, R.D. Penn, and R.A.E. Bakay. 1993;43:1–7. doi.org/10.1212/WNL.43.1_Part_1.1
Autosomal dominant cerebellar phenotypes: The genotype has settled the issue
R.N. Rosenberg. 1995;45:1–5. doi.org/10.1212/WNL.45.1.1
- © 2020 American Academy of Neurology
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.